Quest Diagnostics Inc. (DGX)

102.60
NYSE : Health Services
Prev Close 102.60
Day Low/High 0.00 / 0.00
52 Wk Low/High 90.10 / 112.97
Avg Volume 938.30K
Exchange NYSE
Shares Outstanding 135.82M
Market Cap 13.87B
EPS 5.60
P/E Ratio 18.21
Div & Yield 2.00 (1.82%)

Latest News

Workforce Drug Positivity At Highest Rate In A Decade, Finds Analysis Of More Than 10 Million Drug Test Results

Prescription opiate positivity rate drops by double digits, while cocaine rises by double digits in certain states

Starbucks Leaves a Bitter Taste and Doesn't Suit My Investment Palate Either

Starbucks Leaves a Bitter Taste and Doesn't Suit My Investment Palate Either

For my portfolio, you can't beat this SBUX competitor -- and for a cup of coffee.

Humana, MultiPlan, Optum, Quest Diagnostics And UnitedHealthcare Launch Blockchain-Driven Effort To Tackle Care Provider Data Issues

Humana, MultiPlan, Optum, Quest Diagnostics And UnitedHealthcare Launch Blockchain-Driven Effort To Tackle Care Provider Data Issues

Five leading health care organizations - Humana (NYSE: HUM), MultiPlan, Quest Diagnostics (NYSE: DGX) and UnitedHealth Group's (NYSE: UNH) Optum and UnitedHealthcare - today announced that they are launching a pilot program...

Quest Diagnostics And Rutgers University Announce Sports Science Research Collaboration To Advance Athletic Performance

Quest Diagnostics And Rutgers University Announce Sports Science Research Collaboration To Advance Athletic Performance

Collaboration will leverage insights from Quest's Blueprint for Athletes biometric testing service data to examine physiological changes, performance variables in competitive athletes at thenewly created Quest Diagnostics Sports Science Laboratory at the Rutgers-New Brunswick Center for Health & Human Performance

Quest Diagnostics Completes Acquisition Of MedXM

Quest Diagnostics Completes Acquisition Of MedXM

Transaction expands Quest's scale and reach in the mobile provider segment and bolsters its extended care capabilities

The Really Big Money Rushes to Super Bowl

The Really Big Money Rushes to Super Bowl

This will be the ninth consecutive year when the big game tops that 100 million-viewers mark.

Quest Diagnostics Becomes #71 Most Shorted S&P 500 Component, Replacing Concho Resources

Quest Diagnostics Becomes #71 Most Shorted S&P 500 Component, Replacing Concho Resources

The most recent short interest data has been released for the 12/29/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Quest Diagnostics To Acquire MedXM, Expanding Its Health Risk Assessment Services To Close Gaps In Care

Quest Diagnostics To Acquire MedXM, Expanding Its Health Risk Assessment Services To Close Gaps In Care

Acquisition to strengthen Quest's mobile provider capabilities and population health management solutions for health plans

Quest Diagnostics Completes Acquisition Of Shiel Medical Laboratory From Fresenius Medical Care

Quest Diagnostics Completes Acquisition Of Shiel Medical Laboratory From Fresenius Medical Care

Transaction broadens access to Quest's diagnostic innovations in the New York-New Jersey metropolitan area

Quest Diagnostics Completes Acquisition Of Cleveland HeartLab And Formalizes R&D Collaboration With Cleveland Clinic

Quest Diagnostics Completes Acquisition Of Cleveland HeartLab And Formalizes R&D Collaboration With Cleveland Clinic

Cleveland HeartLab's Laboratory Facility is Now Quest's National Cardiometabolic Center of Excellence, Serving Physicians and Patients Seeking to Identify and Address Hidden Risks of Heart Disease

Quest Diagnostics To Present New Insights In Autoimmune Disease At The 2017 American College Of Rheumatology Meeting

Quest Diagnostics To Present New Insights In Autoimmune Disease At The 2017 American College Of Rheumatology Meeting

Five Presentations Show the Clinical Value of Diagnostic Innovations for Assessing Prevalent Autoimmune Diseases, Including Rheumatoid Arthritis and Lupus

'When I Think of October, I Think of Black Monday' -- Market Recon

'When I Think of October, I Think of Black Monday' -- Market Recon

We all knew that the Ugly Stick would be out on Monday, Oct. 17, 1987.

Quest Diagnostics Becomes #68 Most Shorted S&P 500 Component, Replacing CBOE Holdings

Quest Diagnostics Becomes #68 Most Shorted S&P 500 Component, Replacing CBOE Holdings

The most recent short interest data has been released for the 09/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Quest Diagnostics Becomes #84 Most Shorted S&P 500 Component, Replacing Zions Bancorporation

Quest Diagnostics Becomes #84 Most Shorted S&P 500 Component, Replacing Zions Bancorporation

The most recent short interest data has been released for the 08/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

S&P Stuck in Tight Range

Market hasn't gone down, maybe because it's a little oversold.

Quest Diagnostics Becomes #106 Most Shorted S&P 500 Component, Replacing Perrigo Company

The most recent short interest data has been released for the 05/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Cramer: These Sectors Look Bullish (Part III)

Cramer: These Sectors Look Bullish (Part III)

From Abbott Labs to Wynn, these names rate checking out.

Cramer: There Are Powerful Themes in Several Bull Markets

Cramer: There Are Powerful Themes in Several Bull Markets

It's a wonder to me how split this market really is.

TheStreet Quant Rating: A- (Buy)